Expression of D-type cyclins in mantle cell and diffuse large
B-cell lymphomas

J 2016

Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas

ZLÁMALÍKOVÁ, Lenka, Mojmír MOULIS, David ŠÁLEK, Jiří JARKOVSKÝ, Jan ŠMARDA et. al.

Basic information

Original name

Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas

Authors

ZLÁMALÍKOVÁ, Lenka (203 Czech Republic), Mojmír MOULIS (203 Czech Republic), David ŠÁLEK (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Jan ŠMARDA (203 Czech Republic, belonging to the institution) and Jana ŠMARDOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Oncology Reports, Athens, Spandidos Publications, 2016, 1021-335X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10601 Cell biology

Country of publisher

Greece

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.662

RIV identification code

RIV/00216224:14310/16:00089581

Organization unit

Faculty of Science

DOI

http://dx.doi.org/10.3892/or.2016.4658

UT WoS

000374077700021

Keywords (in Czech)

lymfom mantlových buněk; difúzní lymfom velkých B-buněk; cykliny D; qRT-PCR; immunoblotting

Keywords in English

mantle cell lymphoma; diffuse large B- cell lymphoma; D-type cyclins; qRT-PCR; immunoblotting

Abstract

V originále

D-type cyclins are involved in cell cycle regulation and play an important role in the pathogenesis of lymphomas. Aberrant expression of cyclin D1 is associated with mantle cell lymphoma (MCL) and serves as a diagnostic marker of MCL. Analysis of cyclin D expression in tumor tissues of patients with diffuse large B-cell lymphoma (DLBCL) which comprises a heterogeneous group of tumors may contribute to their stratification. We analyzed expression of cyclin D1, D2, and D3 mRNAs in 30 MCL and 104 DLBCL patients using qRT-PCR and addressed their significance for disease outcome. We confirmed a high level of cyclin D1 mRNA in 29 MCL cases (97%). One case (3%) was identified as positive for cyclin D2. Expression of cyclin D1 was limited to MCL and did not occur in DLBCL. Overexpression of cyclin D2, which is rare in MCL, occurred more frequently in DLBCL (11 cases, 10.6%). We showed that high expression of cyclin D2 in DLBCL cases de novo decreased the overall survival rate (P=0.016) and progression-free survival (P=0.009). The expression pattern of cyclin D3 was similar in both types of studied lymphomas and it did not affect the disease outcome.

Citovat

ZLÁMALÍKOVÁ, Lenka, Mojmír MOULIS, David ŠÁLEK, Jiří JARKOVSKÝ, Jan ŠMARDA and Jana ŠMARDOVÁ. Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas. Oncology Reports. Athens: Spandidos Publications, 2016, vol. 35, No 5, p. 2673-2680. ISSN 1021-335X. Available from: https://dx.doi.org/10.3892/or.2016.4658.

@article{1340365,
   author = {Zlámalíková, Lenka and Moulis, Mojmír and Šálek, David and Jarkovský, Jiří and Šmarda, Jan and Šmardová, Jana},
   article_location = {Athens},
   article_number = {5},
   doi = {http://dx.doi.org/10.3892/or.2016.4658},
   keywords = {mantle cell lymphoma; diffuse large B- cell lymphoma; D-type cyclins; qRT-PCR; immunoblotting},
   language = {eng},
   issn = {1021-335X},
   journal = {Oncology Reports},
   title = {Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas},
   volume = {35},
   year = {2016}
}

TY  - JOUR
ID  - 1340365
AU  - Zlámalíková, Lenka - Moulis, Mojmír - Šálek, David - Jarkovský, Jiří - Šmarda, Jan - Šmardová, Jana
PY  - 2016
TI  - Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas
JF  - Oncology Reports
VL  - 35
IS  - 5
SP  - 2673-2680
EP  - 2673-2680
PB  - Spandidos Publications
SN  - 1021335X
KW  - mantle cell lymphoma
KW  - diffuse large B- cell lymphoma
KW  - D-type cyclins
KW  - qRT-PCR
KW  - immunoblotting
N2  - D-type cyclins are involved in cell cycle regulation and play an important role in the pathogenesis of lymphomas. Aberrant expression of cyclin D1 is associated with mantle cell lymphoma (MCL) and serves as a diagnostic marker of MCL. Analysis of cyclin D expression in tumor tissues of patients with diffuse large B-cell lymphoma (DLBCL) which comprises a heterogeneous group of tumors may contribute to their stratification. We analyzed expression of cyclin D1, D2, and D3 mRNAs in 30 MCL and 104 DLBCL patients using qRT-PCR and addressed their significance for disease outcome. We confirmed a high level of cyclin D1 mRNA in 29 MCL cases (97%). One case (3%) was identified as positive for cyclin D2. Expression of cyclin D1 was limited to MCL and did not occur in DLBCL. Overexpression of cyclin D2, which is rare in MCL, occurred more frequently in DLBCL (11 cases, 10.6%). We showed that high expression of cyclin D2 in DLBCL cases de novo decreased the overall survival rate (P=0.016) and progression-free survival (P=0.009). The expression pattern of cyclin D3 was similar in both types of studied lymphomas and it did not affect the disease outcome.
ER  -

ZLÁMALÍKOVÁ, Lenka, Mojmír MOULIS, David ŠÁLEK, Jiří JARKOVSKÝ, Jan ŠMARDA and Jana ŠMARDOVÁ. Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas. \textit{Oncology Reports}. Athens: Spandidos Publications, 2016, vol.~35, No~5, p.~2673-2680. ISSN~1021-335X. Available from: https://dx.doi.org/10.3892/or.2016.4658.

Detailed Information on Publication Record